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addition of the high concentration ﬂuoride rinse may beneﬁt HCT
patients and potentially decrease the severity and frequency of oral
mucositis. Plan:We plan to conduct a prospective study on the use
of high concentration ﬂuoride rinse in the HCT patients.
Conditioning Regimens (n)
Autologous (14) Allogeneic(11)
HD Melphalan (7) Bu/Flu/Cam (1)
BEAM-R (6) Flu/Mel/Cam (2)
BEAM (1) Cy/TBI/Cam (3)
Bu/Flu/MTX (1)
Cy/TBI/MTX (2)
Bu/Cy/MTX (1)
Mel/TBI (1)
Abbreviations: HD-high dose; BEAM- carmustine, etoposide, cyt-
arabine, melphalan; R-Rituximab; Bu-busulfan; Flu-ﬂudara-
bine; Cam- Alemtuzumab; Mel- melphalan; Cy- cyclophosph-
amide; TBI- total body irradiation; MTX- methotrexate.
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MAKING THE LEAP: SUCCESSFUL INTEGRATION OF A PEDIATRIC BONE
MARROW TRANSPLANT POPULATION WITHIN AN EXISTING ADULT
BONE MARROW TRANSPLANT UNIT
Eron, B.1, Marlow, C.1, Coghill, A.1, Talbert, G.1, Shea, T.1 1Univer-
sity of North Carolina Health Care System, Chapel Hill, NC.
The University of North Carolina Health Care System’s Adult
Bone Marrow and Stem Cell Transplant Program was estab-
lished in 1992. Since that time over 900 transplants have been
performed. In 2004 UNC Health Care System made a commit-
ment to expand the scope of the BMT Program and develop a
pediatric transplant unit. The pediatric hematology/oncology
physicians accurately predicted the need to offer marrow and
stem cell transplants to the children of North Carolina and
surrounding areas. Pediatric patients and their families ex-
pressed a desire to receive comprehensive care at one facility.
Physicians recognized that the successful recruitment of top
pediatric hematologists/oncologists was dependent upon an ac-
credited transplant program. The adult unit at UNC was iden-
tiﬁed as the site for a combined adult-pediatric BMT unit.
Several areas were identiﬁed as pivotal for success. Goals were
established to facilitate the transition. Senior staff, in coopera-
tion with nurse educators, prepared existing staff by providing a
calm, comfortable and safe environment for learning the skills
vital to successful pediatric nursing. A pediatric BMT core
curriculum was developed and updated as protocols and prac-
tices changed. Physicians presented in-services speciﬁc to pedi-
atric diseases. Pediatric nurse educators were available when
questions surfaced about nursing practice and equipment. The
UNCH oncology nursing residency program expanded to in-
corporate adult and pediatric practice. A BMT nurse joined the
pediatric nursing practice group to expand the unit’s knowledge
of pediatric issues. The unit chaplain initiated meetings with
nurses to discuss emotional challenges related to pediatric ill-
ness and death. Psychosocial meetings and family conferences
changed to increase nursing participation. This established a
connection between families and staff prior to admission.
The purpose of this poster is to describe the steps necessary for
successful integration of a pediatric population within an existing
adult bone marrow transplant unit including:
 Insuring that the adult BMT nursing staff felt supported during
this transition
 Educating to insure that clinical skills set and competencies are
adequate
 Providing emotional and spiritual support for staff dealing for
the ﬁrst time with issues surrounding morbidity and mortality in a
pediatric population.
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A BMT-BASED DIABETIC TEACHING PROGRAM: RESPONDING TO THE
NEEDS OF ALLOGENEIC PATIENTS WITH STEROID-INDUCED HYPER-
GLYCEMIA
Estepa-Estrella, J.M.A.1, Johnston, P.1, dela Cruz, B.1,
Austria-Granada, M.L.R.1, Ascuna, J.1 1UT MD Anderson Cancer
Center, Houston, TX.
Allogeneic patients are faced with multi-faceted needs through-
out the transplant process. More than 50% develop graft versus
host disease (GVHD) and are started on high dose steroid therapy
as the frontline treatment. Consequently, due to high dose steroid
therapy, patients develop steroid induced hyperglycemia which is
further aggravated by onset of infections or sepsis. Steroid induced
hyperglycemia poses signiﬁcant risks to allogeneic patients as the
condition persists simultaneously with steroid therapy wherein
dosing depends greatly on severity of symptoms of GVHD. As a
result, patients are faced with challenges that include recovery of
counts, prevention of infection, and managing the ill effects of
steroid induced hyperglycemia.
Patient education is an important role played by nurses in pro-
viding quality patient care. Through an individualized teaching
program, patients are equipped with the essential knowledge and
skills that help them go through the rigors of recuperation. Dia-
betic teaching is imperative for patients and their caregivers to
assist them in coping with the demands of hyperglycemia. Teach-
ings include monitoring and recording blood sugar levels, safe and
effective use of insulin, recognizing and managing acute compli-
cations, diet modiﬁcation and other self-care measures. Since the
BMT patient cannot leave the home unit to attend class held twice
a week by the diabetic educator, individual teaching at earliest
available time needs to be arranged. This frequently results in
delays (beyond institutional guidelines) on the day of discharge.
In response, the discharge nurses were tasked to incorporate
diabetic teaching prior to the patient’s discharge. The outline of
the program was modiﬁed to meet the speciﬁc needs of allogeneic
patients. Signiﬁcantly, patients and caregivers have expressed bet-
ter understanding of the condition and conﬁdence in carrying out
the skills required. Follow-up with the outpatient team is conﬁrm-
ing these outcomes. The diabetic teaching program and education
tool utilized will be presented.
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A CULTURE OF SAFETY: PROMOTING A SAFE ENVIRONMENT ON THE
DUKE PEDIATRIC BLOOD AND MARROW TRANSPLANT UNIT
Frey, M.A.2, Hutchinson, B.2 1Duke University Hospital, Durham, NC;
2The Duke Pediatric Blood and Marrow Transplant Program, Durham,
NC.
Six years ago the, Institute of Medicine (IOM) issued its land-
mark report on medical errors, To Err Is Human: Building a Safer
Health System. The reports ﬁnding indicated that as many as 98,00
people die each year due to medical errors (Leape and Berwick
2005). Many organizations have reviewed this report and have
initiated programs to promote safety. None have take the charge
more seriously than The Duke Pediatric Blood and Marrow
Transplant Unit. This unit is categorized as an intensive care unit.
The unit administers extremely high volumes of medications,
blood products and other supportive therapies. The length of stay
is long and the patients are very tenuous. The purpose of this
poster is to decribe the Duke Pediatric Blood and Marrow Trans-
plant Program Safety Program. This program is aligned with the
JCAHO 2007 National Safety Goals. The objectives of the pro-
gram are to minimize errors, promote safety at all times and instill
a just culture of safety among our staff. The program is led and
strongly supported by physician leaders. It is multidisciplinary in
nature and focuses on all aspects of safety within the inpatient unit.
Major initiatives and accomplishments will be presented.
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“RECOVERY”: DEVELOPMENT OF A BMT DISCHARGE TEACHING PAM-
PHLET
Garavgalia, K.1 1Barnes-Jewish Hospital/Siteman Cancer Center, St.
Louis, MO.
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Background: Bone marrow transplantation is a complex and
often overwhelming experience for patients and their families. The
discharge teaching manual that was being used contained informa-
tion that was minimal and outdated to prepare patients and their
families for recovery after discharge. Inconsistent information was
given to patients among inpatient staff as well as inconsistencies in
education between inpatient and outpatient staff.
Purpose and Objectives: The purpose of this project was to
elaborate and update the extraordinary amount of available infor-
mation for patients and their families into one consistent format. A
discharge teaching pamphlet was developed in order to 1) stan-
dardize information given to patients by nursing staff including
both the inpatient and outpatient settings; 2) provide educational
information below an eighth grade level; and 3) develop an ex-
panded, research-based patient education tool reﬂective of national
standards
Method: The Resource Nurse contacted the CDC, ONS,
IBWA, and three other transplant centers for current practice and
teaching materials. Relevant Barnes-Jewish Hospital policies were
reviewed to verify compliance of educational materials. The gath-
ered information was reviewed by BMT Clinical Nurse Specialists,
Nurse Practitioners, coordinators, pharmacists, social worker and
editorial staff.
Results: The material was published as a professional, colored
pamphlet entitled “Recovery”. All BMT staff was educated to
ensure consistent understanding of information to be provided to
patients. An informal survey of patients who had received “Recov-
ery” found many positive comments from patients and families.
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DEVELOPMENT OF A PEDIATRIC HPC DONOR HISTORY QUESTION-
NAIRE (DHQ)
Halverson, T.L.1 1Children’s Memorial Hospital, Chicago, IL.
Utilizing an adult-oriented donor history questionnaire (DHQ)
to determine donor eligibility for a pediatric donor poses unique
challenges. Questions designed to elicit information about poten-
tial communicable disease risks in adults can be unnecessarily
repetitive or conﬂict with state requirements for pediatric patients.
This has led Children’s Memorial Hospital (CMH) to develop a
pediatric HPC DHQ.
The newly-released (adult) HPC DHQ was developed by an
inter-organizational Donor History Questionnaire-Cellular Ther-
apies Task Force to screen allogeneic hematopoietic progenitor
cell (HPC) donors for communicable disease risk factors in accor-
dance with requirements from the FDA, NMDP, AABB and
FACT. User instructions that accompany the (adult) HPC DHQ
recommend administering the questions without changing the or-
der, wording or content. The (adult) HPC DHQ contains 44
questions; 13 of these questions are related to sexual activity and
sexually transmitted diseases.
In the state of Illinois, children between the ages of 12 and 17
must speciﬁcally authorize release of information pertaining to
sexually transmitted diseases and other “highly conﬁdential” health
information. Therefore, DHQ questions relating to sexually trans-
mitted diseases need to be asked while the parents are not present,
and afﬁrmative responses cannot be shared with the parents / legal
guardians without express written authorization by the 12 to 17
year old child. The order of questions in the newly-released HPC
DHQ hinders separate administration of those questions and thus
compliance with state regulations.
An informal survey of other pediatric transplant facilities across
the United States found signiﬁcant variation in the way that DHQs
were administered to potential pediatric donors. Some institutions
administered each DHQ question to the potential donor’s parents,
while others glossed over or omitted questions relating to sexual
activity when they did not seem relevant. Several respondents
noted the need for a pediatric-oriented HPC DHQ.
To fulﬁll the FDA’s requirement for proper determination of
donor eligibility and adhere to state requirements regarding shar-
ing of “highly conﬁdential” health information in adolescent pa-
tients, CMH’s Stem Cell Transplant Program developed and is
currently adopting a pediatric HPC DHQ that streamlines the
interview process while appropriately screening for potential com-
municable disease risks in the pediatric donor.
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A REIMMUNIZATION PROGRAM FOR PEDIATRIC HEMATOPOIETIC PRO-
GENITOR CELL TRANSPLANT (HPCT) RECIPIENTS
Klinger, E.F.1, Daum, C.D.1 1Children’s Hospital of Orange County,
Orange, CA.
“During the ﬁrst 1-4 years after an allogeneic or autologous
HPCT, antibody titers to vaccine-preventable diseases (e.g., teta-
nus, polio, measles) decline if the recipient is not reimmunized.
Despite return of normal neutrophil and lymphocyte counts, hu-
moral and cellular immunity may take as long as one year to fully
recover after HPCT and these diseases can pose increased risk for
HPCT recipients. To acquire the same immunity as others,
HPCT recipients should be routinely reimmunized. The timing of
reimmunization is dependent upon the type of transplant, the type
of immunosuppressive therapy, and whether or not chronic graft
versus host disease has developed.”(CDC guidelines, 2000 and
Avigan et al, 2001) The Children’s Hospital of Orange County
(CHOC) Blood and Marrow Transplant team developed a pro-
gram that addresses the need for reimmunization of the HPCT
recipient population that 1) increases identiﬁcation and evaluation
of HPCT recipients, 2) communicates current CDC recommen-
dations to medical staff, 3) documents vaccinations utilizing exist-
ing organizational and statewide immunization programs, and 4)
improves overall reimmunization implementation . An immuniza-
tion alert for evaluation 1-year post HPCT is posted on the
patient’s chart. Once deemed eligible, the patient elects to receive
the vaccinations at either CHOC or their community-based phy-
sician’s ofﬁce. The primary physician’s ofﬁce receives a 3  5 inch
abbreviated copy of the CDC recommendations attached to the
yellow California “Immunization Record” card and vaccinations
may be documented on any California Immunization Record form.
Patients receiving vaccinations at CHOC utilizes the organiza-
tional immunization record form with the CDC recommendations
printed on the back for reference. The implementation of this
program ensures that HPCT recipients will experience the same
baseline immunity as others as they return to normalcy.
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THE DEVELOPMENT OF A COMPREHENSIVE QUALITY MANAGEMENT
PLAN IN THE BLOOD AND MARROW STEM CELL TRANSPLANT SETTING
Kurosky, A.S.1, DiBiase, R.1, Carolin, K.1 1Karmanos Cancer Institute,
Detroit, MI.
Background: Quality management (QM) is an essential activity
for blood and marrow stem cell transplant (BMT) programs seek-
ing accreditation by the Foundation for Accreditation of Cellular
Therapy (FACT). It is also an area where deﬁciencies are often
observed by FACT inspectors. The components of a health care
quality management plan (QMP) include the development of a
model for health care improvement that promotes best practice
standards, utilizes these practice standards to guide the manage-
ment of patient care, measures outcomes, and improves critical
processes and practices based on the analysis of outcomes. Our
BMT program’s QMP satisﬁed regulatory requirements but the
structure lacked translation into substantive outcome analysis and
changes if indicated. A restructure of the plan was initiated to
capture these essential components of QM. FRAMEWORK: Rec-
ognizing that the activities of hematopoietic progenitor cell col-
lection, processing and the clinical care of patients receiving a
transplant are integrated, the BMT program within this National
Cancer Institute designated comprehensive cancer facility devel-
oped a multi-disciplinary QMP. An overview of the design and
implementation of the QMP will be presented including: a) the
organizational structure of the QM committee including the lead-
ership with ﬁnal responsibility for the QMP and the personnel
responsible for execution of key activities; b) identiﬁcation and
development of pertinent policies and procedures in collection,
laboratory and clinical facilities and those shared across the pro-
gram; c) selection of key measures and processes for audit and
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